FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of Mayne Pharma Pty

Halcygen to acquire wholly owned subsidiary of Hospira

28-Sep-2009 - HalcyGen Pharmaceuticals Limited has entered into a definitive agreement with Hospira Australia Pty Ltd, a wholly owned subsidiary of Hospira Inc., to acquire all the outstanding shares in Mayne Pharma International Pty Ltd (MPI) – one of the businesses Hospira purchased when it acquired Mayne ...

license agreements New Zealand

Hospira Announces $2 Billion Agreement to Acquire Mayne Pharma

22-Sep-2006 - Hospira, Inc. and Mayne Pharma Limited announced that the companies have entered into an agreement for Hospira to acquire Mayne. Under the terms of the agreement, Mayne shareholders will receive AUD$4.10 cash per outstanding ordinary share of Mayne, or a total equity consideration of ...

PLIVA and Mayne Pharma Finalise Agreement to Continue Development of G-CSF

31-Jul-2006 - PLIVA d.d. announced that it has finalised an agreement with Mayne Pharma for the continued development of biosimilar granulocyte-colony stimulating factor (G-CSF) for the European, South East Asian, Middle Eastern and Asia Pacific markets. This agreement is an amendment of the collaboration ...

Mayne acquires Supergen's North American oncology products

26-Jun-2006 - Mayne Pharma Limited and SuperGen, Inc. have signed a definitive agreement for Mayne Pharma to acquire the North American rights to Nipent® (pentostatin for injection) and SurfaceSafe(TM) from SuperGen, Inc. for a total maximum consideration of US$34 million inclusive of approximately US$14 ...

chemotherapy leukemia oncology +1